OpenAlex
PricingAboutJobs
Log inGet started
Work

HSD3B1 genotype and abiraterone (Abi) metabolites in patients (pts) with prostate cancer (PCa).

HTML

Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2018.36.6_suppl.325
Authors: Hamid Emamekhoo, Mohammad Alyamani, Sunho Park, Jennifer Taylor, Nima Almassi, Sunil Upadhyay, Allison Janine Tyler, Mike Berk, Tae Hyun Hwang, Petros Grivas, Brian I. Rini, Jorge A. Garcia, Richard J. Auchus, Nima Sharifi
Institutions: University of Wisconsin–Madison, Cleveland Clinic, Northern Lincolnshire and Goole Hospitals NHS Foundation Trust, University of Michigan
Language: English

Topic: Prostate Cancer Treatment and Research
Subfield: Cancer Research
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: HSD3B1, abiraterone, prostate cancer, castration-resistant prostate cancer, drug metabolites, 3β-hydroxysteroid dehydrogenase, germline mutations, CYP17 inhibition, androgen metabolism, predictive biomarkers
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2791663105
Cites:
Cited by: 3
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms